+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Contineum Therapeutics

CTNMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$19.64

0.31.53%

At close: -

$19.63

-0.0050-0.03%

After Hours: 4:02 PM EDT

Q3 2024 Earnings were released on Wed Nov 6th, after the market close

Contineum Therapeutics (CTNM) Forecast

News

Earnings Contineum Therapeutics (CTNM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Contineum Therapeutics (NASDAQ:CTNM) Stock

Contineum Therapeutics Stock (NASDAQ: CTNM)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, November 07, 2024

RBC Capital Maintains Outperform on Contineum...
Benzinga Newsdesk

Wednesday, November 06, 2024

Contineum Therapeutics Q3 EPS $(0.40) Beats $...
Benzinga Newsdesk

Tuesday, October 22, 2024

Baird Initiates Coverage On Contineum Therape...
Benzinga Newsdesk

Wednesday, August 14, 2024

RBC Capital Maintains Outperform on Contineum...
Benzinga Newsdesk

Tuesday, August 13, 2024

Contineum Therapeutics Q2 Adj $(0.39) Misses ...
Benzinga Newsdesk

Wednesday, July 31, 2024

Contineum Therapeutics Announces Publication ...
Benzinga Newsdesk

Thursday, May 16, 2024

Contineum Therapeutics Q3 EPS $(3.55), Cash P...
Benzinga Newsdesk

Tuesday, April 30, 2024

RBC Capital Initiates Coverage On Contineum T...
Benzinga Newsdesk
Stifel Initiates Coverage On Contineum Therap...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Contineu...
Benzinga Newsdesk

Tuesday, April 16, 2024

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor

Friday, April 05, 2024

Trading Halt: Halt status updated at 10:10:00...
Benzinga Newsdesk
Reported Earlier, Contineum Therapeutics Pric...
Benzinga Newsdesk

Thursday, April 04, 2024

Contineum Therapeutics, Inc To Start Trading Tomorrow
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved